©The Author(s) 2025.
World J Gastrointest Surg. Mar 27, 2025; 17(3): 94286
Published online Mar 27, 2025. doi: 10.4240/wjgs.v17.i3.94286
Published online Mar 27, 2025. doi: 10.4240/wjgs.v17.i3.94286
Table 4 Clinical characteristics of 85 patients with advanced gastric signet ring cell carcinoma, n (%)
| Characteristic | Value |
| Sex | |
| Women | 50 (58.8) |
| Men | 35 (41.2) |
| Age (year) | |
| Median | 69 |
| Range | 65-78 |
| ECOG | |
| 0 | 48 (56.5) |
| 1 | 28 (32.9) |
| 2 | 9 (10.6) |
| Primary tumor site | |
| Esophagogastric junction | 28 (32.9) |
| Gastric body/fundus | 23 (27.1) |
| Gastric antrum | 19 (22.4) |
| Leather stomach | 15 (17.6) |
| Organs involved | |
| Lymph nodes | 51 (60.0) |
| Liver | 31 (36.4) |
| Lung | 9 (10.6) |
| Peritoneum | 30 (35.3) |
| Other | 10 (11.8) |
| Number of organs involved | |
| 1 | 23 (27.1) |
| 2 | 33 (38.8) |
| > 2 | 29 (34.1) |
- Citation: Liu M, Feng B, He N, Yan R, Qin J. Efficacy of fluorouracil combined with paclitaxel and oxaliplatin for the treatment of advanced gastric signet ring cell carcinoma. World J Gastrointest Surg 2025; 17(3): 94286
- URL: https://www.wjgnet.com/1948-9366/full/v17/i3/94286.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i3.94286